Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 114

1.

Bridging the TB data gap: in silico extraction of rifampicin-resistant tuberculosis diagnostic test results from whole genome sequence data.

Ng KCS, Ngabonziza JCS, Lempens P, de Jong BC, van Leth F, Meehan CJ.

PeerJ. 2019 Aug 26;7:e7564. doi: 10.7717/peerj.7564. eCollection 2019.

2.

Sensitivity of point-of-care testing C reactive protein and procalcitonin to diagnose urinary tract infections in Dutch nursing homes: PROGRESS study protocol.

Kuil SD, Hidad S, Fischer JC, Harting J, Hertogh CM, Prins JM, van Leth F, de Jong MD, Schneeberger C.

BMJ Open. 2019 Aug 10;9(8):e031269. doi: 10.1136/bmjopen-2019-031269.

3.

Management of patients with multidrug-resistant tuberculosis.

Lange C, Aarnoutse RE, Alffenaar JWC, Bothamley G, Brinkmann F, Costa J, Chesov D, van Crevel R, Dedicoat M, Dominguez J, Duarte R, Grobbel HP, Günther G, Guglielmetti L, Heyckendorf J, Kay AW, Kirakosyan O, Kirk O, Koczulla RA, Kudriashov GG, Kuksa L, van Leth F, Magis-Escurra C, Mandalakas AM, Molina-Moya B, Peloquin CA, Reimann M, Rumetshofer R, Schaaf HS, Schön T, Tiberi S, Valda J, Yablonskii PK, Dheda K.

Int J Tuberc Lung Dis. 2019 Jun 1;23(6):645-662. doi: 10.5588/ijtld.18.0622.

PMID:
31315696
4.

Changes in disclosure, adherence and healthcare interactions after the introduction of immediate ART initiation: an analysis of patient experiences in Swaziland.

Molemans M, Vernooij E, Dlamini N, Shabalala FS, Khan S, van Leth F, Gomez GB, Reis R.

Trop Med Int Health. 2019 May;24(5):563-570. doi: 10.1111/tmi.13214. Epub 2019 Mar 3.

5.

Rethinking Antimicrobial Resistance Surveillance: A Role for Lot Quality Assurance Sampling.

Ginting F, Sugianli AK, Bijl G, Saragih RH, Kusumawati RL, Parwati I, de Jong MD, Schultsz C, van Leth F.

Am J Epidemiol. 2019 Apr 1;188(4):734-742. doi: 10.1093/aje/kwy276.

6.

The Tuberculosis Network European Trials group (TBnet) ERS Clinical Research Collaboration: addressing drug-resistant tuberculosis through European cooperation.

van Leth F, Brinkmann F, Cirillo DM, Dheda K, Duarte R, Guglielmetti L, Kuksa L, Lange C, Mitnick C, Skrahina A, Zaman K, Bothamley G.

Eur Respir J. 2019 Jan 3;53(1). pii: 1802089. doi: 10.1183/13993003.02089-2018. Print 2019 Jan. No abstract available.

PMID:
30606765
7.

Pharmacy-based hypertension care employing mHealth in Lagos, Nigeria - a mixed methods feasibility study.

Nelissen HE, Cremers AL, Okwor TJ, Kool S, van Leth F, Brewster L, Makinde O, Gerrets R, Hendriks ME, Schultsz C, Osibogun A, Van't Hoog AH.

BMC Health Serv Res. 2018 Dec 4;18(1):934. doi: 10.1186/s12913-018-3740-3.

8.

Predictive value of the urinary dipstick test in the management of patients with urinary tract infection-associated symptoms in primary care in Indonesia: a cross-sectional study.

Ginting F, Sugianli AK, Kusumawati RL, Parwati I, de Jong MD, Schultsz C, van Leth F.

BMJ Open. 2018 Aug 29;8(8):e023051. doi: 10.1136/bmjopen-2018-023051.

9.

Testing for LTBI: more of the same or a step forward?

van Leth F, Sester M.

Int J Tuberc Lung Dis. 2018 Jun 1;22(6):591. doi: 10.5588/ijtld.18.0267. No abstract available.

PMID:
29862938
10.

Time to revise WHO-recommended definitions of MDR-TB treatment outcomes.

Lange C, van Leth F, Mitnick CD, Dheda K, Günther G.

Lancet Respir Med. 2018 Apr;6(4):246-248. doi: 10.1016/S2213-2600(18)30104-8. No abstract available.

PMID:
29595505
11.

Treatment responses in multidrug-resistant tuberculosis in Germany.

Heyckendorf J, van Leth F, Avsar K, Glattki G, Günther G, Kalsdorf B, Müller M, Olaru ID, Rolling T, Salzer HJF, Schuhmann M, Terhalle E, Lange C.

Int J Tuberc Lung Dis. 2018 Apr 1;22(4):399-406. doi: 10.5588/ijtld.17.0741.

12.

Clinical Management of Multidrug-Resistant Tuberculosis in 16 European Countries.

Günther G, van Leth F, Alexandru S, Altet N, Avsar K, Bang D, Barbuta R, Bothamley G, Ciobanu A, Crudu V, Danilovits M, Dedicoat M, Duarte R, Gualano G, Kunst H, de Lange W, Leimane V, McLaughlin AM, Magis-Escurra C, Muylle I, Polcová V, Popa C, Rumetshofer R, Skrahina A, Solodovnikova V, Spinu V, Tiberi S, Viiklepp P, Lange C; for TBNET.

Am J Respir Crit Care Med. 2018 Aug 1;198(3):379-386. doi: 10.1164/rccm.201710-2141OC.

PMID:
29509468
13.

Relapse-free cure from multidrug-resistant tuberculosis in Germany.

Heyckendorf J, van Leth F, Kalsdorf B, Olaru ID, Günther G, Salzer HJF, Terhalle E, Rolling T, Glattki G, Müller M, Schuhmann M, Avsar K, Lange C.

Eur Respir J. 2018 Feb 21;51(2). pii: 1702122. doi: 10.1183/13993003.02122-2017. Print 2018 Feb. No abstract available.

14.

Reply: Benefit of the Shorter Multidrug-Resistant Tuberculosis Treatment Regimen in California and Modified Eligibility Criteria.

van Leth F, Günther G, Hoffmann H, Lange C; European MDR-TB Database Collaboration.

Am J Respir Crit Care Med. 2017 Dec 1;196(11):1489-1490. doi: 10.1164/rccm.201705-0995LE. No abstract available.

PMID:
28715229
15.

Treatment outcomes of MDR-TB and HIV co-infection in Europe.

Magis-Escurra C, Günther G, Lange C, Alexandru S, Altet N, Avsar K, Bang D, Barbuta R, Bothamley G, Ciobanu A, Crudu V, Davilovits M, Dedicoat M, Duarte R, Gualano G, Kunst H, de Lange W, Leimane V, McLaughlin AM, Muylle I, Polcová V, Popa C, Rumetshofer R, Skrahina A, Solodovnikova V, Spinu V, Tiberi S, Viiklepp P, van Leth F; for TBnet.

Eur Respir J. 2017 Jun 8;49(6). pii: 1602363. doi: 10.1183/13993003.02363-2016. Print 2017 Jun. No abstract available.

16.

An easy tool to assess ventilation in health facilities as part of air-borne transmission prevention: a cross-sectional survey from Uganda.

Brouwer M, Katamba A, Katabira ET, van Leth F.

BMC Infect Dis. 2017 May 3;17(1):325. doi: 10.1186/s12879-017-2425-6.

17.

Tuberculosis resistance-conferring mutations with fitness cost among HIV-positive individuals in Uganda.

Ssengooba W, Lukoye D, Meehan CJ, Kateete DP, Joloba ML, de Jong BC, Cobelens FG, van Leth F.

Int J Tuberc Lung Dis. 2017 May 1;21(5):531-536. doi: 10.5588/ijtld.16.0544.

PMID:
28399968
18.

Rapid assessment of antimicrobial resistance prevalence using a Lot Quality Assurance sampling approach.

van Leth F, den Heijer C, Beerepoot M, Stobberingh E, Geerlings S, Schultsz C.

Future Microbiol. 2017 Apr;12:369-377. doi: 10.2217/fmb-2016-0170. Epub 2017 Mar 24.

PMID:
28339294
19.

Tuberculosis Treatment Outcomes in Europe: Based on Treatment Completion, Not Cure.

Dedicoat MJ, Günther G, Crudu V, Duarte R, Gualano G, Magis-Escurra C, Rumetshofer R, Skrahina A, Spinu V, Tiberi S, Viiklepp P, van Leth F, Lange C; for TBNET ‡.

Am J Respir Crit Care Med. 2017 Nov 1;196(9):1222-1224. doi: 10.1164/rccm.201612-2585LE. No abstract available.

PMID:
28323453
20.

Antimicrobial resistance in uropathogens and appropriateness of empirical treatment: a population-based surveillance study in Indonesia.

Sugianli AK, Ginting F, Kusumawati RL, Pranggono EH, Pasaribu AP, Gronthoud F, Geerlings S, Parwati I, De Jong MD, Van Leth F, Schultsz C.

J Antimicrob Chemother. 2017 May 1;72(5):1469-1477. doi: 10.1093/jac/dkw578.

21.

More on Treatment Outcomes in Multidrug-Resistant Tuberculosis.

Lange C, Günther G, van Leth F; TBNET.

N Engl J Med. 2016 Dec 29;375(26):2611. doi: 10.1056/NEJMc1613123. No abstract available.

PMID:
28029919
22.

Prevention of Early Mortality by Presumptive Tuberculosis Therapy Study: An Open Label, Randomized Controlled Trial.

Manabe YC, Worodria W, van Leth F, Mayanja-Kizza H, Traore AN, Ferro J, Pakker N, Frank M, Grobusch MP, Colebunders R, Cobelens F.

Am J Trop Med Hyg. 2016 Dec 7;95(6):1265-1271. Epub 2016 Oct 17.

23.

Effect of secondary preventive therapy on recurrence of tuberculosis in HIV-infected individuals: a systematic review.

Bruins WS, van Leth F.

Infect Dis (Lond). 2017 Mar;49(3):161-169. doi: 10.1080/23744235.2016.1262059. Epub 2016 Dec 2. Review. Erratum in: Infect Dis (Lond). 2017 Apr;49(4):320.

PMID:
27911140
24.

Population impact of factors associated with prevalent pulmonary tuberculosis in Tanzania.

Senkoro M, Kumar AM, Chinnakali P, Mfinanga SG, Egwaga S, Kamara V, van Leth F, Hinderaker SG.

Int J Tuberc Lung Dis. 2016 Oct;20(10):1326-1333. Erratum in: Int J Tuberc Lung Dis. 2017 Sep 1;21(9):1070.

PMID:
27725043
25.

Limited Benefit of the New Shorter Multidrug-Resistant Tuberculosis Regimen in Europe.

Lange C, Duarte R, Fréchet-Jachym M, Guenther G, Guglielmetti L, Olaru ID, Oliveira O, Rumetshofer R, Veziris N, van Leth F; European MDR-TB database collaboration *.

Am J Respir Crit Care Med. 2016 Oct 15;194(8):1029-1031. No abstract available.

PMID:
27685538
26.

Treatment Outcomes in Multidrug-Resistant Tuberculosis.

Günther G, Lange C, Alexandru S, Altet N, Avsar K, Bang D, Barbuta R, Bothamley G, Ciobanu A, Crudu V, Danilovits M, Dedicoat M, Duarte R, Gualano G, Kunst H, de Lange W, Leimane V, Magis-Escurra C, McLaughlin AM, Muylle I, Polcová V, Popa C, Rumetshofer R, Skrahina A, Solodovnikova V, Spinu V, Tiberi S, Viiklepp P, van Leth F; for TBNET.

N Engl J Med. 2016 Sep 15;375(11):1103-5. doi: 10.1056/NEJMc1603274. No abstract available.

27.
28.

Prevalence of pulmonary tuberculosis in adult population of Tanzania: a national survey, 2012.

Senkoro M, Mfinanga S, Egwaga S, Mtandu R, Kamara DV, Basra D, Fundikira L, Kahwa A, Shirima R, Range N, Hinderaker SG, van Leth F.

Int J Tuberc Lung Dis. 2016 Aug;20(8):1014-21. doi: 10.5588/ijtld.15.0340.

PMID:
27393533
29.

Factors associated with poor knowledge among adults on tuberculosis in Bangladesh: results from a nationwide survey.

Hossain S, Zaman K, Quaiyum A, Banu S, Husain A, Islam A, Borgdorff M, van Leth F.

J Health Popul Nutr. 2015 May 1;34:2. doi: 10.1186/s41043-015-0002-4.

30.

Viral Load and Risk of Tuberculosis in HIV Infection.

Lange C, van Leth F, Sester M; TBnet.

J Acquir Immune Defic Syndr. 2016 Feb 1;71(2):e51-3. doi: 10.1097/QAI.0000000000000834. No abstract available.

PMID:
26761521
31.

TB-HIV co-infection in the Netherlands: estimating prevalence and under-reporting in national registration databases using a capture-recapture analysis.

van Leth F, Evenblij K, Wit F, Kiers A, Sprenger H, Verhagen M, Hillebregt M, Kalisvaart N, Schimmel H, Verbon A.

J Epidemiol Community Health. 2016 Jun;70(6):556-60. doi: 10.1136/jech-2015-206680. Epub 2015 Dec 23.

PMID:
26700301
32.

Beyond multidrug-resistant tuberculosis in Europe: a TBNET study.

Günther G, van Leth F, Altet N, Dedicoat M, Duarte R, Gualano G, Kunst H, Muylle I, Spinu V, Tiberi S, Viiklepp P, Lange C; TBNET.

Int J Tuberc Lung Dis. 2015 Dec;19(12):1524-7. doi: 10.5588/ijtld.15.0274.

PMID:
26614196
33.

Latent tuberculosis infection as a target for tuberculosis control.

van Leth F, van Crevel R, Brouwer M.

Future Microbiol. 2015;10(6):905-8. doi: 10.2217/fmb.15.30. No abstract available.

34.

Health care-seeking behaviour among people with cough in Tanzania: findings from a tuberculosis prevalence survey.

Senkoro M, Hinderaker SG, Mfinanga SG, Range N, Kamara DV, Egwaga S, van Leth F.

Int J Tuberc Lung Dis. 2015 Jun;19(6):640-6. doi: 10.5588/ijtld.14.0499.

PMID:
25946352
35.

Multidrug-resistant tuberculosis in Europe, 2010-2011.

Günther G, van Leth F, Alexandru S, Altet N, Avsar K, Bang D, Barbuta R, Bothamley G, Ciobanu A, Crudu V, Davilovits M, Dedicoat M, Duarte R, Gualano G, Kunst H, de Lange W, Leimane V, Magis-Escurra C, McLaughlin AM, Muylle I, Polcová V, Pontali E, Popa C, Rumetshofer R, Skrahina A, Solodovnikova V, Spinu V, Tiberi S, Viiklepp P, Lange C; TBNET.

Emerg Infect Dis. 2015 Mar;21(3):409-16. doi: 10.3201/eid2103.141343.

36.

Implementation of tuberculosis infection prevention and control in Mozambican health care facilities.

Brouwer M, Coelho E, das Dores Mosse C, van Leth F.

Int J Tuberc Lung Dis. 2015 Jan;19(1):44-9. doi: 10.5588/ijtld.14.0337.

PMID:
25519789
37.

Healthcare workers' challenges in the implementation of tuberculosis infection prevention and control measures in Mozambique.

Brouwer M, Coelho E, Mosse Cd, Brondi L, Winterton L, van Leth F.

PLoS One. 2014 Dec 15;9(12):e114364. doi: 10.1371/journal.pone.0114364. eCollection 2014.

38.

Availability, price and affordability of anti-tuberculosis drugs in Europe: a TBNET survey.

Günther G, Gomez GB, Lange C, Rupert S, van Leth F; TBNET.

Eur Respir J. 2015 Apr;45(4):1081-8. doi: 10.1183/09031936.00124614. Epub 2014 Nov 13.

39.

Risk assessment of tuberculosis in immunocompromised patients. A TBNET study.

Sester M, van Leth F, Bruchfeld J, Bumbacea D, Cirillo DM, Dilektasli AG, Domínguez J, Duarte R, Ernst M, Eyuboglu FO, Gerogianni I, Girardi E, Goletti D, Janssens JP, Julander I, Lange B, Latorre I, Losi M, Markova R, Matteelli A, Milburn H, Ravn P, Scholman T, Soccal PM, Straub M, Wagner D, Wolf T, Yalcin A, Lange C; TBNET.

Am J Respir Crit Care Med. 2014 Nov 15;190(10):1168-76. doi: 10.1164/rccm.201405-0967OC.

PMID:
25303140
40.

Validation of indirect tuberculosis treatment adherence measures in a resource-constrained setting.

Mkopi A, Range N, Lwilla F, Egwaga S, Schulze A, Geubbels E, van Leth F.

Int J Tuberc Lung Dis. 2014 Jul;18(7):804-9. doi: 10.5588/ijtld.13.0675.

PMID:
24902556
41.

Antimicrobial drug resistance among clinically relevant bacterial isolates in sub-Saharan Africa: a systematic review.

Leopold SJ, van Leth F, Tarekegn H, Schultsz C.

J Antimicrob Chemother. 2014 Sep;69(9):2337-53. doi: 10.1093/jac/dku176. Epub 2014 May 30. Review.

PMID:
24879668
42.

Care seeking in tuberculosis: results from a countrywide cluster randomised survey in Bangladesh.

Hossain S, Zaman K, Quaiyum A, Banu S, Husain A, Islam A, Borgdorff M, van Leth F.

BMJ Open. 2014 May 28;4(5):e004766. doi: 10.1136/bmjopen-2013-004766.

43.

Embracing the challenges of HIV-TB co-infection in children.

van Leth F, Kampmann B.

Int J Tuberc Lung Dis. 2014 Apr;18(4):379. doi: 10.5588/ijtld.14.0171. No abstract available.

PMID:
24670688
44.

Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement.

Lange C, Abubakar I, Alffenaar JW, Bothamley G, Caminero JA, Carvalho AC, Chang KC, Codecasa L, Correia A, Crudu V, Davies P, Dedicoat M, Drobniewski F, Duarte R, Ehlers C, Erkens C, Goletti D, Günther G, Ibraim E, Kampmann B, Kuksa L, de Lange W, van Leth F, van Lunzen J, Matteelli A, Menzies D, Monedero I, Richter E, Rüsch-Gerdes S, Sandgren A, Scardigli A, Skrahina A, Tortoli E, Volchenkov G, Wagner D, van der Werf MJ, Williams B, Yew WW, Zellweger JP, Cirillo DM; TBNET.

Eur Respir J. 2014 Jul;44(1):23-63. doi: 10.1183/09031936.00188313. Epub 2014 Mar 23.

45.

Design of pragmatic trials of tuberculosis interventions.

Cobelens F, van Leth F, van 't Hoog A.

Lancet. 2014 Jan 18;383(9913):213-4. doi: 10.1016/S0140-6736(14)60065-9. No abstract available.

PMID:
24439729
46.

Antiretroviral therapy and tuberculosis: does the regimen matter?

van Leth F, Wit FW, Hermans SM.

Expert Rev Anti Infect Ther. 2014 Jan;12(1):5-7. doi: 10.1586/14787210.2014.859984.

PMID:
24256498
47.

Epidemiology of tuberculosis in an urban slum of Dhaka City, Bangladesh.

Banu S, Rahman MT, Uddin MK, Khatun R, Ahmed T, Rahman MM, Husain MA, van Leth F.

PLoS One. 2013 Oct 21;8(10):e77721. doi: 10.1371/journal.pone.0077721. eCollection 2013.

48.

TB diagnostic process management of patients in a referral hospital in Mozambique in comparison with the 2007 WHO recommendations for the diagnosis of smear-negative pulmonary TB and extrapulmonary TB.

Bos JC, Smalbraak L, Macome AC, Gomes E, van Leth F, Prins JM.

Int Health. 2013 Dec;5(4):302-8. doi: 10.1093/inthealth/iht025. Epub 2013 Oct 14.

PMID:
24130098
49.

Tuberculin survey in Bangladesh, 2007-2009: prevalence of tuberculous infection and implications for TB control.

Hossain S, Zaman K, Banu S, Quaiyum MA, Husain MA, Islam MA, Cooreman E, Borgdorff M, van Leth F.

Int J Tuberc Lung Dis. 2013 Oct;17(10):1267-72. doi: 10.5588/ijtld.13.0114.

PMID:
24025376
50.

Comparison of direct versus concentrated smear microscopy in detection of pulmonary tuberculosis.

Uddin MK, Chowdhury MR, Ahmed S, Rahman MT, Khatun R, van Leth F, Banu S.

BMC Res Notes. 2013 Jul 25;6:291. doi: 10.1186/1756-0500-6-291.

Supplemental Content

Loading ...
Support Center